Navigation Links
Oncothyreon announces webcast of fourth quarter and year end 2008 financial results conference call
Date:3/3/2009

SEATTLE, March 3 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX:ONY), a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer, today announced that it intends to release its fourth quarter and year end 2008 financial results on Monday, March 9, 2009 after the close of the U.S. and Canadian markets. Following the release, Oncothyreon's management expects to discuss these financial results and give a general business update in a conference call at 4:30 p.m. EST.

The discussion is planned for a live webcast and can be accessed at www.oncothyreon.com under the "News & Events" section. It is expected that the archive of the webcast will be available approximately one hour after completion of the discussion and will be posted on the Oncothyreon website for 30 days.

About Oncothyreon

Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon's goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com.


'/>"/>
SOURCE Oncothyreon Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Oncothyreon to present at BIO CEO & Investor Conference 2009
2. Oncothyreon reports third quarter 2008 financial results
3. Oncothyreon to present at Rodman & Renshaw Annual Global Investment Conference
4. Oncothyreon announces November 6th webcast of third quarter 2008 financial results and corporate update conference call
5. Oncothyreon to present at BIO Investor Forum 2008
6. Oncothyreon announces receipt of NASDAQ letter regarding compliance with NASDAQ Global Market listing standards
7. Oncothyreon announces prioritization plan for development programs
8. Oncothyreon announces receipt of notice of non-compliance with market value of listed securities standard for listing on The NASDAQ Global Market
9. Oncothyreon initiates Phase 1 trial of PX-866 cancer compound
10. Oncothyreon initiates Phase 1b trial of PX-12 in patients with advanced metastatic cancer
11. Oncothyreon to receive milestone payment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... MA (PRWEB) May 19, 2013 The ... social media training online, has proudly announced that the ... small business has surpassed 175,000 views on YouTube. The ... social media and SEO tips and training for small ... my students find the YouTube tips helpful for their ...
(Date:5/17/2013)... German . ... eye, you can see which branch a bird is sitting ... through the telephoto lens for high-magnification images requires considerable skill. ... to study proteins, the active biomolecules of cells. , Olga ... Systems Biology, and her colleagues have now come up with ...
(Date:5/17/2013)... PALO ALTO, Calif. , May 17, 2013 ... that it has achieved 50% enrollment of the ... trial to evaluate the safety and preliminary efficacy ... Progenitor Cells) therapy for Knee Osteoarthritis (KOA). To ... Effect (SAE) reported. The Phase I ...
(Date:5/17/2013)... The paradigm of ‘one drug, one ... can help predict the adverse and therapeutic effects of ... of Computational Biology at the Genomics Laboratory, Covance, will ... high-quality genomics when used as part of the QC ... data sets to identify key clinical targets even in ...
Breaking Biology Technology:YouTube Channel on SEO Tips Surpasses 175,000 Views, Announces JM Internet Group 2Proteome atlas for the tuberculosis pathogen 2Proteome atlas for the tuberculosis pathogen 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2
... RESEARCH TRIANGLE PARK, N.C., Jan. 9 Quintiles,Transnational ... its,Global Central Laboratories and Clinical Development Services (CDS) ... China., The new consolidated Quintiles China facility, ... located at Sun Dong Ann Plaza in Beijing, ...
... Burrill Merchant Banking acted as,exclusive financial advisor ... (teduglutide) with Nycomed.,Under the terms of the agreement, ... to Nycomed for the treatment of gastrointestinal disorders., ... for the treatment of,short-bowel syndrome (SBS). SBS can ...
... MATEO, Calif., Jan. 9 NeurogesX, Inc.,(Nasdaq: NGSX ... therapies, today announced that it completed a $25.0,million private ... of,its late stage portfolio of novel pain management therapies., ... on Sunday, December,23, 2007, it entered into a securities ...
Cached Biology Technology:Quintiles Central Lab, Clinical Development in China to Expand, Relocate to New Facility 2Burrill Merchant Banking Advises NPS on Phase III Licensing Agreement 2NeurogesX Closes $25 Million Private Placement 2NeurogesX Closes $25 Million Private Placement 3NeurogesX Closes $25 Million Private Placement 4
(Date:5/17/2013)... Sustainable Global Logistics Operations) is aiming to cut CO2 ... intermodal loading systems and the boosting of intelligent systems ... with experience in the logistics sector and in supply ... a duration of three and a half years. , ... components and ontologies shared by the users, objects and ...
(Date:5/16/2013)... 2013) Illustrating a commitment to the support ... Association (AGA) Research Foundation has announced the inaugural ... Award recipients. Supported by the National Institute of ... new award helps underrepresented minority students to further ... research. , "By establishing this new award, AGA ...
(Date:5/16/2013)... scientists have used ancient shorelines to predict the stability of ... a high shoreline from three million years ago, for example ... were thought to be evidence of a high sea level ... has led many scientists to think that if the world,s ... do just the same in our modern, progressively warming world. ...
Breaking Biology News(10 mins):New logistics services that will cut energy consumption and CO2 emissions 2Underrepresented minority students receive fellowships in digestive disease and nutrition research 2World's biggest ice sheets likely more stable than previously believed 2
... While studying how a cell keeps its genetic material intact, ... two catalysts vital to managing a yeast cell's energy. They ... of them led the cell to turn off 70 percent ... unprepared for such a dramatic event," says Jef Boeke, Ph.D., ...
... A new study reveals how the production of a ... in natural killer (NK) cells, immune cells that typically ... IFNg, produced by NK cells and other cell types, ... in defending against tumor cells. However, overproduction of IFNg ...
... Massachusetts General Hospital (MGH) researchers have identified potential ovarian ... of treating these tumors with standard chemotherapy. Understanding ... lead to new approaches to treating ovarian cancer, which ... their fifth most common cause of cancer death. The ...
Cached Biology News:Johns hopkins researchers find link between cell's energy use and genome health 2Johns hopkins researchers find link between cell's energy use and genome health 3Research reveals control of potent immune regulator 2Mass. General study finds potential ovarian cancer stem cells 2
...
Jak3 Antibody Ship: Hot Store: -20 C...
WASF2 Immunogen: WASF2 (NP_008921, 73 a.a. ~ 173 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Applications: Western blotting Stability: Room temperature, indefinitely ...
Biology Products: